PeptiDream
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates.
Launch date
Employees
Market cap
$2.5b
Enterprise valuation
$2.4b (Public information from Sep 2024)
Share price
JPY2565 4587.T
Tokyo Japan (HQ)
Financials
Estimates*
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 11.7b | 9.4b | 26.9b | 28.7b | 46.0b | 40.3b | 44.3b |
| % growth | - | (20 %) | 187 % | 7 % | 60 % | (12 %) | 10 % |
| EBITDA | 8.5b | 5.0b | 10.9b | 9.0b | 24.3b | 16.6b | 18.1b |
| % EBITDA margin | 73 % | 53 % | 41 % | 31 % | 53 % | 41 % | 41 % |
| Profit | 4.4b | 3.6b | 7.6b | 3.0b | 16.2b | 10.7b | 12.4b |
| % profit margin | 38 % | 39 % | 28 % | 11 % | 35 % | 26 % | 28 % |
| EV / revenue | 55.8x | 34.0x | 10.2x | 6.8x | 6.8x | 7.5x | 6.6x |
| EV / EBITDA | 76.5x | 63.7x | 25.1x | 21.6x | 12.9x | 18.2x | 16.2x |
| R&D budget | - | 1.7b | 2.9b | 3.2b | - | - | - |
| R&D % of revenue | - | 18 % | 11 % | 11 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Early VC | |
JPY299m | Late VC | ||
| N/A | N/A | IPO | |
| Total Funding | $2.3m | ||
